Targeting PAD4 as well as NOX resulted in significant attenuation of thrombus formation in cerebral microvessels, thereby providing a proof of principle and a potential viable therapeutic strategy to target thromboinflammation driven stroke pathogenesis 53. The gene discussed is PADI4; the disease is Stroke.